An immunomodulator is a substance that modifies, or modulates, the immune system to help your body respond to a disease or illness. Different immunomodulators can affect different parts of the ...

Thankfully the team at Oncovir, Inc. aren’t desensitized. They are harnessing the potential of their groundbreaking immunomodulator, Hiltonol (Poly-ICLC), to develop important cancer therapies ...

Here, we report the efficacy and safety results regarding xalnesiran regimens with or without an immunomodulator, ruzotolimod or pegylated interferon (peginterferon) alfa-2a, in persons who had ...

1,2,3,4,5 "We are pleased to have taken this important step in advancing our EOM613 COVID-19 program as we pursue EOM613 as the first dual-acting, broad-spectrum immunomodulator designed to treat ...

The highest percentages of patients with HBsAg loss were observed in the groups that received xalnesiran plus an immunomodulator. The most frequent grade 3 or 4 adverse event was elevated ALT.

In addition, further to the Company's announcement on 20 September 2023, it has received the fully granted patent for Immunomodulator I from the Japanese Patent Office. Poolbeg has a worldwide ...

If you have moderate to severe psoriasis, or if light therapy and medicines you spread on your skin don’t clear your skin, your doctor may prescribe an immunomodulator. Which Types of ...

a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is pleased to report exciting ...

The trial also met key secondary endpoints. A phase 2 clinical trial of VVN461, a nonsteroidal dual Janus kinase 1/tyrosine kinase 2 immunomodulator, met the primary endpoint of statistical and ...